CID 71597445

Lasiocepsin

Structural Information

Molecular Formula
C129H234N38O28S4
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)CN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@@H](NC2=O)CCCCN)CC(C)C)CCCCN)CC(C)C)C(C)C)CCCCN)C(=O)O)CCCCN)CCCCN)CCCCN)CCCCN)C
InChI
InChI=1S/C129H234N38O28S4/c1-17-76(13)103-125(191)145-78(15)105(171)148-83(41-22-30-52-133)110(176)151-84(42-23-31-53-134)111(177)149-80(38-19-27-49-130)107(173)142-65-100(169)146-82(40-21-29-51-132)109(175)159-94-68-198-199-70-96(128(194)195)162-114(180)86(44-25-33-55-136)154-121(187)95(161-124(190)102(75(11)12)163-118(184)91(62-73(7)8)156-113(179)85(43-24-32-54-135)153-116(182)89(60-71(3)4)157-122(188)97-47-36-58-166(97)101(170)66-143-108(174)81(150-120(94)186)39-20-28-50-131)69-197-196-67-93(119(185)144-79(16)106(172)164-103)160-117(183)90(61-72(5)6)158-126(192)104(77(14)18-2)165-115(181)87(45-26-34-56-137)152-112(178)88(46-35-57-141-129(139)140)155-123(189)98-48-37-59-167(98)127(193)92(63-74(9)10)147-99(168)64-138/h71-98,102-104H,17-70,130-138H2,1-16H3,(H,142,173)(H,143,174)(H,144,185)(H,145,191)(H,146,169)(H,147,168)(H,148,171)(H,149,177)(H,150,186)(H,151,176)(H,152,178)(H,153,182)(H,154,187)(H,155,189)(H,156,179)(H,157,188)(H,158,192)(H,159,175)(H,160,183)(H,161,190)(H,162,180)(H,163,184)(H,164,172)(H,165,181)(H,194,195)(H4,139,140,141)/t76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,102-,103-,104-/m0/s1
InChIKey
KDHJQRBJNSBOFR-QKSXZUPSSA-N
Compound name
(1R,6R,9S,12S,15S,18S,21S,24S,30S,33R,36S,45S,48S,51S,54S,57S,62S,65R)-6-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-18,21,24,30,36,51,62-heptakis(4-aminobutyl)-12-[(2S)-butan-2-yl]-9,15-dimethyl-48,54-bis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,46,49,52,55,58,60,63-nonadecaoxo-57-propan-2-yl-3,4,67,68-tetrathia-8,11,14,17,20,23,26,29,32,35,38,41,47,50,53,56,59,61,64-nonadecazatricyclo[31.26.10.041,45]nonahexacontane-65-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

3
References

0
Patents

2891.6938 Da
Monoisotopic Mass

-4.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2892.7011 257.9
[M+Na]+ 2914.6830 254.3
[M-H]- 2890.6865 256.3
[M+NH4]+ 2909.7276 253.5
[M+K]+ 2930.6570 248.6
[M+H-H2O]+ 2874.6911 239.3
[M+HCOO]- 2936.6920 253.3
[M+CH3COO]- 2950.7077 254.2
[M+Na-2H]- 2912.6685 279.0
[M]+ 2891.6933 231.5
[M]- 2891.6943 231.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.